Entinostat

Overview

Entinostat is an oral and selective class I HDAC inhibitor, with IC 50 s of 243 nM, 453 nM, and 248 nM for HDAC1 , HDAC2 , and HDAC3 , respectively.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-12163
• CAS No.: 209783-80-2
• Molecular Formula: C21H20N4O3
• Molecular Weight: 376.41
• Purity: 99.98%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: ≥ 2.5 mg/mL (6.64 mM); Clear solution
• Availability: In-stock

Source

Original product source